Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Rowland-Jones

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
AIDS (London, England)|April 2, 2014
The protective effect of HIV-2 infection: implications for understanding HIV-1 immunityPhyllis J Kanki, Sarah Rowland-Jones
Immunotherapy Advances|November 29, 2023
DC-targeting lentivectors for cancer immunotherapyEster Gea-Mallorquí, Sarah Rowland-Jones
Nature Reviews. Immunology|July 4, 2024
Rethinking pDCs: a questionable ally in immunity?Ester Gea-Mallorquí, Sarah Rowland-Jones
Plos Medicine|May 9, 2008
Resisting immune exhaustion in HIV-1 infectionSarah Rowland-Jones, Thushan de Silva
The Lancet. HIV|May 13, 2024
Closing the equity gap in the treatment of HIV-2 infectionSarah Rowland-Jones, Ester Gea-Mallorquí
F1000Research|May 23, 2017
Recent advances in understanding HIV evolutionSophie M Andrews, Sarah Rowland-Jones
F1000 Biology Reports|October 16, 2010
Lessons from the failure of the adenovector HIV vaccineMarie-Eve Blais, Sarah Rowland-Jones
Immunology Letters|December 3, 2014
How does the humoral response to HIV-2 infection differ from HIV-1 and can this explain the distinct natural history of infection with these two human retroviruses?Shokouh Makvandi-Nejad, Sarah Rowland-Jones
Frontiers in Microbiology|November 20, 2014
How can we design better vaccines to prevent HIV infection in women?Hannah Rafferty, Sengeziwe Sibeko, Sarah Rowland-Jones
Journal of HIV Therapy|January 30, 2003
HIV-1 and AIDS: what are protective immune responses?Tara Beattie, Sarah Rowland-Jones, Rupert Kaul
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
AIDS (London, England)|April 2, 2014
The protective effect of HIV-2 infection: implications for understanding HIV-1 immunityPhyllis J Kanki, Sarah Rowland-Jones
Immunotherapy Advances|November 29, 2023
DC-targeting lentivectors for cancer immunotherapyEster Gea-Mallorquí, Sarah Rowland-Jones
Nature Reviews. Immunology|July 4, 2024
Rethinking pDCs: a questionable ally in immunity?Ester Gea-Mallorquí, Sarah Rowland-Jones
Plos Medicine|May 9, 2008
Resisting immune exhaustion in HIV-1 infectionSarah Rowland-Jones, Thushan de Silva
The Lancet. HIV|May 13, 2024
Closing the equity gap in the treatment of HIV-2 infectionSarah Rowland-Jones, Ester Gea-Mallorquí
F1000Research|May 23, 2017
Recent advances in understanding HIV evolutionSophie M Andrews, Sarah Rowland-Jones
F1000 Biology Reports|October 16, 2010
Lessons from the failure of the adenovector HIV vaccineMarie-Eve Blais, Sarah Rowland-Jones
Immunology Letters|December 3, 2014
How does the humoral response to HIV-2 infection differ from HIV-1 and can this explain the distinct natural history of infection with these two human retroviruses?Shokouh Makvandi-Nejad, Sarah Rowland-Jones
Frontiers in Microbiology|November 20, 2014
How can we design better vaccines to prevent HIV infection in women?Hannah Rafferty, Sengeziwe Sibeko, Sarah Rowland-Jones
Journal of HIV Therapy|January 30, 2003
HIV-1 and AIDS: what are protective immune responses?Tara Beattie, Sarah Rowland-Jones, Rupert Kaul
Pageof 15